Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Medicine

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AJO.2006.11.002PMID 16887404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin for the Prevention of Cardiovascular Events

  2006cited by this paper
• Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

  2005cited by this paper
• Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.

  2005cited by this paper
• Narrative Review: Aspirin Resistance and Its Clinical Implications

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.

  2005cited by this paper
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.

  2004cited by this paper
• Triflusal vs aspirin for prevention of cerebral infarction

  2004cited by this paper
• Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

  2004cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trials

  2004cited by this paper
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

  2004cited by this paper
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

  2004cited by this paper
• Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial.

  2004cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation

  2003cited by this paper
• Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction: The TACIP Study: A Randomized, Double-Blind, Multicenter Trial

  2003cited by this paper
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Randomized, Double-Blind, Placebo-Controlled, International Trial of the Oral IIb/IIIa Antagonist Lotrafiban in Coronary and Cerebrovascular Disease

  2003cited by this paper
• Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.

  2003cited by this paper
• Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial.

  2002cited by this paper
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

  2002cited by this paper
• Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.

  2002cited by this paper
• Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study.

  2002cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and Rationale

  2002cited by this paper
• Risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin for the prevention of cardiovascular diseases

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Warfarin, aspirin, or both after myocardial infarction.

  2002cited by this paper
• Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy

  2002cited by this paper
• Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events.

  2002cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task Force

  2002cited by this paper
• Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• Ticlopidine versus aspirin after myocardial infarction (STAMI) trial.

  2001cited by this paper
• Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.

  2001cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke.

  2001cited by this paper
• Primäre Prävention kardiovaskulärer Ereignisse durch ASS und Vitamin E PPP das “Primary Prevention Project”

  2001cited by this paper
• Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

  2001cited by this paper
• Platelets modulate gastric ulcer healing: Role of endostatin and vascular endothelial growth factor release

  2001cited by this paper
• Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

  2001cited by this paper
• A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.

  2001cited by this paper
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.

  2000cited by this paper
• Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial. The SYMPHONY Investigators. Sibrafiban versus Aspirin to Yield Maximum Protection from Ischemic Heart Events Post-acute Coronary Syndromes.

  2000cited by this paper
• Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

  2000cited by this paper
• Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial.

  2000cited by this paper
• Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study.

  2000cited by this paper
• Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group.

  1999cited by this paper
• Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.

  1999cited by this paper
• Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

  1999cited by this paper
• Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators.

  1999cited by this paper
• Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.

  1999cited by this paper
• Comparative Safety and Tolerability of Clopidogrel and Aspirin

  1999cited by this paper
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators.

  1999cited by this paper
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

  1998cited by this paper
• Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators.

  1997cited by this paper
• Effectiveness of low-dose ASA in prevention of secondary ischemic stroke, the ASA Study Group in Taiwan.

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

  1996cited by this paper
• Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial

  1996cited by this paper
• Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.

  1995cited by this paper
• Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group.

  1995cited by this paper
• Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty.

  1995cited by this paper
• Lack of Effect of Aspirin in Asymptomatic Patients with Carotid Bruits and Substantial Carotid Narrowing

  1995cited by this paper
• Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

  1995cited by this paper
• Endarterectomy for asymptomatic carotid artery stenosis

  1995cited by this paper
• Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

  1994cited by this paper
• Trapidil (Triazolopyrimidine), a Platelet‐Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results of the Randomized, Double‐Blind STARC Study

  1994cited by this paper
• Acetylsalicylic acid--reocclusion--prophylaxis after angioplasty (ARPA-study). A randomized double-blind trial of two different dosages of ASA in patients with peripheral occlusive arterial disease.

  1994cited by this paper
• AHFS Drug Information

  1994cited by this paper
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke

  1993cited by this paper
• Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis.

  1993cited by this paper
• Adverse effects of low‐dose aspirin in a healthy elderly population

  1993cited by this paper
• Aspirin Versus Coumadin in the Prevention of Reocclusion and Recurrent Ischemia After Successful Thrombolysis: A Prospective Placebo‐Controlled Angiographic Study Results of the APRICOT Study

  1993cited by this paper
• Does Low‐Dose Acetylsalicylic Acid Prevent Stroke After Carotid Surgery?: A Double‐blind, Placebo‐Controlled Randomized Trial

  1993cited by this paper
• Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

  1992cited by this paper
• Stroke Prevention in Atrial Fibrillation Study: Final Results

  1991cited by this paper
• The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.

  1991cited by this paper
• Effects of low-dose aspirin on restenosis after coronary angioplasty.

  1991cited by this paper
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990

  1991cited by this paper
• A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke.

  1991cited by this paper
• Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group.

  1991cited by this paper
• Immediate Postoperative Aspirin Improves Vein Graft Patency Early and Late After Coronary Artery Bypass Graft Surgery: A Placebo‐Controlled, Randomized Study

  1991cited by this paper
• Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.

  1990cited by this paper
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group.

  1990cited by this paper
• Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusion.

  1990cited by this paper
• Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

  1989cited by this paper
• Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

  1989cited by this paper
• Final report on the aspirin component of the ongoing Physicians' Health Study.

  1989cited by this paper
• Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.

  1983cited by this paper
• A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

  1974cited by this paper

• Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis

  2025cites this paper
• Small intestinal bacteria accelerate aspirin-induced small intestinal injuries.

  2025cites this paper
• Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers

  2025cites this paper
• Current and potentially novel antithrombotic treatment in acute ischemic stroke.

  2024cites this paper
• Gastrointestinal Bleeding After Percutaneous Coronary Intervention: Incidence, Risk Factors, and Outcomes

  2024cites this paper
• Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

  2024influential citation
• A Study on the Effectiveness of Mono and Dual Antiplatelet Therapy in Secondary Prevention of Vascular Events

  2024cites this paper
• An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?

  2024influential citation
• A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs

  2024cites this paper
• Impact of low-dose aspirin on the prevalence of anemia in elderly patients: a systematic review and meta-analysis

  2024cites this paper
• Lower extremity arterial disease perspective: IUA consensus document on "lead management". Part 1.

  2023cites this paper
• Venous Thromboembolism and Bleeding after Transurethral Resection of the Prostate (TURP) in Patients with Preoperative Antithrombotic Therapy: A Single-Center Study from a Tertiary Hospital in China

  2023cites this paper
• Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis

  2023cites this paper
• Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease

  2023cites this paper
• Discontinuation of antiplatelet therapy after stent-assisted coil embolization for cerebral aneurysms

  2023cites this paper
• Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke

  2023cites this paper
• The association between acetylsalicylic acid and subarachnoid haemorrhage: the Framingham Heart Study

  2023cites this paper
• Long-Term Comparison of Cilostazol versus Clopidogrel in Secondary Prevention of Noncardioembolic Ischemic Stroke

  2023cites this paper
• Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors.

  2023cites this paper
• ACUPUNCTURE AND RELATED TECHNIQUES FOR POSTOPERATIVE PAIN : A SYSTEMATIC REVIEW

  2023cites this paper
• Lower extremity arterial disease

  2023cites this paper
• Aspirin and Subarachnoid Haemorrhage in the UK Biobank

  2022cites this paper
• Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches

  2022cites this paper
• Anticoagulant and Antiplatelet Therapy in Periprocedural Period of Elective Gastrointestinal Endoscopy

  2022cites this paper
• Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.

  2022cites this paper
• Aspirin and cancer: biological mechanisms and clinical outcomes

  2022cites this paper
• Risk-benefit analysis of emergency vaccine use

  2022cites this paper
• Protective Effect of Irsogladine against Aspirin-Induced Mucosal Injury in Human Induced Pluripotent Stem Cell-Derived Small Intestine

  2022cites this paper
• Risk-benefit analysis of emergency vaccine use

  2022cites this paper
• Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum

  2022cites this paper
• Recommendations from the ICM-VTE: General.

  2022cites this paper
• Risk factors for antiplatelet drug–associated intracranial hemorrhage: a systematic review and meta-analysis

  2022cites this paper
• Rare case of intracerebral hemorrhage in anaphylactic shock following administration of intramuscular adrenaline: A case report

  2022cites this paper
• Strongly increased risk of gastric and duodenal ulcers among new users of low‐dose aspirin: results from two large cohorts with new‐user design

  2022cites this paper
• Nonsteroidal Antiinflammatory Drugs, Anticoagulation, and Upper Gastrointestinal Bleeding.

  2021cites this paper
• Trends in Incidence of Intracerebral Hemorrhage and Association With Antithrombotic Drug Use in Denmark, 2005-2018

  2021cites this paper
• Rare Case of a Giant Left Atrium With Cerebrovascular Accident

  2021cites this paper
• Factors for unsuccessful endoscopic hemostasis in patients with severe peptic ulcer bleeding

  2021cites this paper
• Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Rationale and Design of the Multicenter Randomized Occlusion-AF Trial.

  2021cites this paper
• A 75-Year-Old Female with Left Anterior Descending Coronary Artery Originating from the Right Coronary Artery Presenting with Recurrent Major Bleeding due to Dual Antiplatelet Therapy Managed with Percutaneous Coronary Intervention and Ticagrelor Monotherapy

  2021cites this paper
• Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK – Results from micro-simulation model

  2021cites this paper
• Polypragmasy as a therapeutic problem among palliative and geriatric patients

  2021cites this paper
• Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers

  2021cites this paper
• A meta-analysis of aspirin and subarachnoid hemorrhage in patients with intracranial aneurysms yields different results to the general population

  2021cites this paper
• Neurologic complications of atrial fibrillation: Pharmacologic and interventional approaches to stroke prevention.

  2021cites this paper
• Bleeding and Clotting Disorders

  2021cites this paper
• Neurological complications of cardiovascular drugs.

  2021cites this paper
• Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic® Software

  2021cites this paper
• Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.

  2021cites this paper
• ASPC Manual of Preventive Cardiology

  2021influential citation
• Big Data Analysis of the Risk of Intracranial Hemorrhage in Korean Populations Taking Low-Dose Aspirin.

  2021cites this paper
• Common Analgesics for Relieving Pain in Pediatric Dentistry (Overview)

  2020cites this paper
• Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score

  2020cites this paper
• The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study.

  2020cites this paper
• Die untere gastrointestinale Blutung

  2020cites this paper
• Discordance between the Clinical Presentation and Morphology of Myocardial Infarction in a Patient with Acute Post-Hemorrhagic Anemia

  2020cites this paper
• Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.

  2020cites this paper
• Geriatric Gastroenterology: A Gastroenterologist’s Perspective

  2020cites this paper
• Direct Oral Anticoagulants and Coronary Artery Disease: The Debacle of Aspirin Era?

  2020cites this paper
• Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived Galectin-3.

  2020cites this paper
• Management of bleeding and procedures in patients on antiplatelet therapy.

  2020cites this paper
• To determine the frequency of intracerebral haemorrhage (ICH) in patients taking antiplatelet therapy.

  2020cites this paper
• Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay

  2020cites this paper
• Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes

  2020cites this paper
• Evaluating the safety of early surgery for ruptured intracranial aneurysms in patients with long-term aspirin use: a propensity score matching study

  2020cites this paper
• Factors associated with the use of gastrointestinal medicines amoung older people with intellectual disabilities in Ireland

  2020cites this paper
• Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial.

  2019cites this paper
• Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease

  2019cites this paper
• Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies

  2019cites this paper
• Isolation, Characterization and Cardioprotective Potential of Gratissinol from Chloroform Extract of Ocimum Gratissimum (Linn.) Leaves

  2019cites this paper
• Bleeding risk assessment for stroke patients on antithrombotic therapy

  2019cites this paper
• Acute Respiratory Distress Syndrome Associated With Clopidogrel in a Young Male Patient

  2019cites this paper
• Antithrombotic drugs do not increase intraoperative blood loss in emergency gastrointestinal surgery: a single-institution propensity score analysis

  2019cites this paper
• The Protective Effect of Teprenone on Aspirin-Related Gastric Mucosal Injuries

  2019cites this paper
• Antiplatelet Drug Management

  2019cites this paper
• Managing the Elderly Emergency Department Patient

  2019cites this paper
• Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

  2019cites this paper
• Antithrombotic dose: some observations from published clinical trials.

  2019cites this paper
• NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period?

  2019cites this paper
• Bleeding risk assessment for stroke patients on antithrombotic therapy.

  2019cites this paper
• Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel

  2019cites this paper
• Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines

  2019cites this paper
• Mono versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

  2018cites this paper
• Resumption of antiplatelet therapy in patients with primary intracranial haemorrhage: Balancing benefits and risks.

  2018cites this paper
• Management of Antithrombotic-Related Intracerebral Hemorrhage

  2018cites this paper
• Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

  2018cites this paper
• Evaluation and management of Non-variceal upper gastrointestinal bleeding.

  2018cites this paper
• Aspirin use and endometrial cancer risk and survival.

  2018cites this paper
• Gastrointestinale Blutung

  2018influential citation
• Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.

  2018cites this paper
• Anticoagulation in the cardiac patient: A concise review

  2018cites this paper
• Ethnobotanical, phytochemical and therapeutic effects of Myrtus communis L. berries seeds on gastrointestinal tract diseases: a review

  2018cites this paper
• Postoperative anticoagulation after free flap reconstruction for head and neck cancer: A systematic review

  2018cites this paper
• A Small Bowel Ulcer due to Clopidogrel with Cytomegalovirus Enteritis Diagnosed by Capsule and Double-Balloon Endoscopy

  2018cites this paper
• The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial

  2018cites this paper
• Effect of systemic long-term, low-dose aspirin on periodontal status and soluble CD14 in gingival crevicular fluid: a case-control study.

  2018cites this paper
• The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study

  2018cites this paper
• ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)

  2017cites this paper
• Preoperative Low-Dose Aspirin Exposure and Outcomes After Emergency Neurosurgery for Traumatic Intracranial Hemorrhage in Elderly Patients

  2017cites this paper
• Incidence and Clinical Characteristics of Upper Gastrointestinal Bleeding in Patients with Antithrombotic Therapy

  2017cites this paper